Epigenetics-Based Therapeutics: A New Era in Precision Medicine
The Epigenetics-Based Therapeutics market was valued at USD 1.76 Billion in 2024 and is expected to reach USD 5.17 Billion by 2032, growing at a CAGR of 14.4% (2025-2032). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.
